Gerard Thompson1, Antoine Vallatos1, Haitham Al-Mubarak2, Lesley Gilmour3, Joanna Birch3, Lindsay Gallagher2, James Mullin2, Adam Waldman1, William M Holmes2, and Anthony J Chalmers3
1Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom, 2Glasgow Experimental MRI Centre, University of Glasgow, Glasgow, United Kingdom, 3Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom
Synopsis
Assessing the imaging boundary of
glioblastoma multiforme (GBM) has potential to characterize phenotypic
invasiveness relevant to outcomes. Preoperative apparent diffusion coefficient (ADC) changes across
this boundary predicts outcome in humans. The tissue specificity of this
finding is unknown, hindering the interpretation, further development, and
application of the technique. We selected and assessed a relevant preclinical murine infiltrating GBM orthotopic human xenograft
model with a novel histological tissue tumor load assessment to investigate relationships
between ADC on imaging and cellular infiltration. A robust and strong inverse correlation between the
histological tumor infiltration measure and ADC transition is demonstrated, supporting the
hypothesis that ADC changes across GBM boundaries represent tumor infiltration
and therefore relate to the previously-proposed invasive phenotype imaging biomarker.
INTRODUCTION
Glioblastoma
multiforme (GBM) remains a therapeutic challenge, with small increases in dismal
outcomes despite numerous clinical trials. There have been significant recent developments
in molecular characterization, although grading remains primarily histopathological.
While molecular subtypes of GBM are associated with differential outcomes, whole
lesion categorical grading and characterization from a small sample eschews intratumoral
genetic and/or phenotypic heterogeneity relevant to diagnosis, prognosis, and
treatment. Maximal safe cytoreductive surgery is a therapeutic ideal, generally
precluding the tissue-diagnostic enhancing component from the longitudinal
disease process. Non-enhancing infiltrative disease ultimately drives treatment
failure and is increasingly studied. Largely obscured within surrounding FLAIR
abnormality, interrogation of infiltrating tumor is challenging, with comparatively
low tumor burden and intact blood-brain barrier limiting even highly sensitive
positron emission tomography (PET) techniques. Imaging assessment of tumor margins shows promise in molecular subtyping1, characterizing potentially-invasive
behavior beyond the enhancement2,3, and providing relevant spatial
heterogeneity information3. A challenge to prior tumor margin clinical
research stems from ADC non-specificity4, and the multiple serial biopsies required
to determine tissue specificity are problematic. We aimed to investigate the contribution
of microscopic tumor burden in an infiltrating GBM model to ADC changes at the macroscopic margin, to better characterize this previously-described predictive relationship between
pre-operative tumor margin ADC transition values in humans, and disease
outcome.METHODS
Human-derived G7 GBM
orthotopic xenografts were implanted into 8 CD1 nude mice5. T2-, and diffusion-weighted
images (DWI) were acquired on a 7T Bruker platform5. Brains were extracted and fresh-frozen
to minimise fixation artefacts and preserve morphology for matched slicing and imaging
co-registration5. Sections were stained with a human leucocyte antigen (HLA) marker complex which binds specifically to the human-derived GBM cells, with minimal
non-specific background binding. Confocal tile photomicrographs of normalised
HLA binding at 10x magnification were obtained5. Standard structural MR,
diffusion-weighted MR, and HLA-ligand slices were rigidly co-registered, and resampled
to match DWI. The tumor margin was visually delineated on the largest section
at the margin of the low ADC region, informed by the tumor mass visible on
T2w imaging. Linear sampling profiles were defined perpendicular to boundary voxels3,
and spatially-congruent values of ADC and HLA were measured at 13 serial centrifugal
locations over a length of 0.7 mm with linear interpolation. Spearman’s rho was
calculated in each subject for every tumor margin profile and adjusted for
multitest comparison using Bonferroni correction. These properties were
assigned to the boundary voxels to allow subjective visual assessment and overlay comparison
to the structural images.RESULTS
Five mice were suitable
for analysis following imaging and histological preparation. Examples of a
lesion with margin profiles on ADC and HLA images, Spearman’s rho, and
adjusted p-value are shown in figure 1. Summary plots of the values of ADC and
HLA across all measured tumor margin profiles and locations are shown in figure 2. In
>80% of tumor boundaries measured in each subject, there was a statistically
significant strong inverse correlation between ADC and HLA following multitest correction. On visual review, areas with insignificant/direct correlation represented
physical boundaries such as ependyma/ventricular margin, or artefact e.g. from
folding/misregistration of cryosections following histological preparation.DISCUSSION
Characterizing invasive
disease which ultimately leads to treatment failure in GBM remains challenging.
While WHO 2016 molecular markers and histological grading relate to origins and
groupwise prognosis, such binary categorizations do not capture the treatment
relevant heterogeneity nor adverse phenotypic behaviors at the individual
level. Research predominantly focuses on enhancing disease components which augur molecular diagnosis; fewer groups interrogate the challenging non-enhancing FLAIR abnormality. Margin assessment provides an opportunity to characterize tumor at the
interface between predominantly dividing bulk tumor, and the more invasive cells infiltrating parenchyma. Histopathological characterization of this region in humans carries significant
limitations. Using proliferation markers does not capture non-dividing,
infiltrating cells, while H&E is non-specific. Xenografts provide an
opportunity for comprehensive and sensitive cellular infiltration detection since HLA is
exclusive to human glioblastoma cells, surface binding on dividing and
migrating cells. A drawback is that cryopreparation limits subsequent traditional
histological assessment, precluding more detailed comparison without further
dedicated experiments. There is strong inverse correlation between tumor margin HLA and ADC values for almost all profiles at the tumor-parenchyma
interface. This indicates that the ADC profiles relate to tumor infiltration
as previously hypothesised. The mechanism requires further investigation, e.g.
to assess potential perfusion contributions to the ADC measurements used here.
CONCLUSION
ADC values across
the macroscopic tumor margin are robustly inversely correlated with HLA measures
of tumor infiltration/cellularity at the microscopic level in this relevant preclinical model. This indicates that ADC is related to cellularity here, and is therefore a
potentially useful biomarker of infiltrative phenotype. Spatial characterization could provide useful structural and heterogeneity information, although further experiments are required.Acknowledgements
Antoine Vallatos was funded by GEMRIC, the Glasgow Experimental MRI Centre.References
1. Jenkinson, M. D. et al.
(2007) J. Magn. Reson. Imaging, 26: 1405–1412. (doi:10.1002/jmri.21062)
2. Thompson, G. et al. (2009) Proceedings 17th Scientific
Meeting of the International Society of Magnetic Resonance in Medicine (ISMRM):
p2803
3. Thompson, G. et al. (2013) Proceedings 51st Annual
Meeting of the American Society of Neuroradiology (ASNR): p302
4. Eidel, O. et al. (2016) PLoS ONE 11(7): e0160250
5. Holmes, W. M. et al. (2017) Magnetic Resonance in Medicine, (doi:10.1002/mrm.26706) (PMID:28516482)